Cancer remains one of the world’s most serious health threats, especially when it spreads beyond its original site. That ...

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

New UAB research uncovers how NFAT helps uterine NK cells support early placenta development, shedding light on pregnancy health and the roots of complications like preeclampsia.

A new discovery from UC San Diego researchers could enable easier treatment of high-grade serous ovarian cancer, the most common and aggressive form of ovarian cancer.

High-grade serous ovarian cancer is the most common and aggressive form of ovarian cancer and often becomes resistant to ...

Explore new findings on ovarian cancer and how blocking focal adhesion kinase can enhance immune response in treatment.

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...

Growing neurons rely on chemical cues to find their targets, but new research shows that the brain’s physical properties help ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...

A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to ...

Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against ...

A group of international researchers just made a breakthrough in understanding what drives skin cancer growth, as well as how tumors are able to evade our immune system’s defenses. Analyzing the ...